- Home
- ITRG vs ALVR Comparison
ITRG vs ALVR Comparison
Compare ITRG & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- ALVR
- Stock Information
- Founded
- ITRG 1997
- ALVR 2013
- Country
- ITRG Canada
- ALVR United States
- Employees
- ITRG N/A
- ALVR N/A
- Industry
- ITRG Precious Metals
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITRG Basic Materials
- ALVR Health Care
- Exchange
- ITRG Nasdaq
- ALVR Nasdaq
- Market Cap
- ITRG 84.2M
- ALVR 87.7M
- IPO Year
- ITRG N/A
- ALVR 2020
- Fundamental
- Price
- ITRG $1.20
- ALVR $0.90
- Analyst Decision
- ITRG Strong Buy
- ALVR Sell
- Analyst Count
- ITRG 1
- ALVR 5
- Target Price
- ITRG $3.75
- ALVR $1.00
- AVG Volume (30 Days)
- ITRG 259.4K
- ALVR 155.6K
- Earning Date
- ITRG 11-12-2024
- ALVR 11-04-2024
- Dividend Yield
- ITRG N/A
- ALVR N/A
- EPS Growth
- ITRG N/A
- ALVR N/A
- EPS
- ITRG N/A
- ALVR N/A
- Revenue
- ITRG N/A
- ALVR N/A
- Revenue This Year
- ITRG N/A
- ALVR N/A
- Revenue Next Year
- ITRG $360.53
- ALVR N/A
- P/E Ratio
- ITRG N/A
- ALVR N/A
- Revenue Growth
- ITRG N/A
- ALVR N/A
- 52 Week Low
- ITRG $0.64
- ALVR $0.58
- 52 Week High
- ITRG $1.28
- ALVR $2.49
- Technical
- Relative Strength Index (RSI)
- ITRG 66.49
- ALVR 69.10
- Support Level
- ITRG $0.95
- ALVR $0.74
- Resistance Level
- ITRG $1.28
- ALVR $0.91
- Average True Range (ATR)
- ITRG 0.07
- ALVR 0.06
- MACD
- ITRG 0.01
- ALVR 0.01
- Stochastic Oscillator
- ITRG 77.27
- ALVR 94.50
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.